Genome Pharmaceuticals Wins $5.7 Million in Government Financing

MUNICH--Genome Pharmaceu ticals, a functional genomics company here, secured DM 10 million in government funding, half from a state agency and half from a federal agency, in a recent financing round. The company announced plans to establish a unique combination of three genomic databases holding detailed information on genes, expression profiles, and protein interaction networks to identify and validate novel drug targets for diseases that cannot be treated effectively. Those plans will be carried out in collaboration with other unnamed biotechnology and pharmaceutical companies, the company said.